Tiotropium in asthma poorly controlled with standard combination therapy.

By H. Kerstjens, M. Engel, R. Dahl, P. Paggiaro, E. Beck, M. Vandewalker, R. Sigmund, W. Seibold, P. Moroni-Zentgraf, E. Bateman. New England Journal of Medicine, 2012

641 citations recorded by the source corpus.

Subfields: Animal Science and Zoology, Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/1f7357cf15ee5b085a898029527179d4802aeecb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. Sally E. Wenzel
2. Ian M. Adcock
3. P. Barnes

In Pulmonary and Respiratory Medicine

1. Sally E. Wenzel
2. P. Barnes

Citations in the corpus

• International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma (2013, background): “In patients taking high doses of ICSs and LABAs, the addition of tiotropium bromide provided improvements in FEV1, reduced as-needed use of short-acting β2-adrenergic agonists and modestly reduced the risk of a severe exacerbation [244, 246].”